SELF - BREATHE for Chronic Breathlessness
A Self -Guided, Internet -Based Intervention for Patients With Chronic Breathlessness (SELF-BREATHE): an Interview Study.
2 other identifiers
observational
25
1 country
1
Brief Summary
Semi-structured qualitative interviews will be conducted to understand key factors that would enable / facilitate patients with chronic breathlessness to potentially use an online breathlessness intervention (SELF-BREATHE).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 3, 2020
CompletedFirst Submitted
Initial submission to the registry
July 7, 2020
CompletedFirst Posted
Study publicly available on registry
July 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2020
CompletedSeptember 2, 2021
September 1, 2021
5 months
July 7, 2020
September 1, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Descriptive qualitative analysis of patients' preferences, values and motivations that would influence the use of an online self - management intervention for chronic breathlessness (SELF-BREATHE).
Qualitative data
12 months
Study Arms (1)
Patients with Chronic Breathlessness
Patients with Chronic Breathlessness
Interventions
None. Qualitative research interviews to be conducted
Eligibility Criteria
COPD, Cancer, Heart Failure, Interstitial Lung disease, Dyspnea
You may qualify if:
- Adult patients \>18 years of age, with the ability to read, converse in English and able to provide informed consent
- Chronic breathlessness on exertion and or rest (MRC dyspnea score \>2)
- Advanced disease such as cancer, chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF) or interstitial lung disease (ILD), where the underlying disease is deemed to be optimally medically managed by the referring clinician / allied health professional / clinical nurse specialist
You may not qualify if:
- Breathlessness of unknown cause
- A primary diagnosis of chronic hyperventilation syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Hospital NHS Trustlead
- King's College Londoncollaborator
Study Sites (1)
King's College Hospital NHS Foundation Trust
London, SE5 9RS, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles C Reilly, PhD,MSc,BSc
King's College Hospital NHS Trust
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2020
First Posted
July 10, 2020
Study Start
June 3, 2020
Primary Completion
November 11, 2020
Study Completion
November 11, 2020
Last Updated
September 2, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share